{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:32:12Z","timestamp":1770219132998,"version":"3.49.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1378\/chest.108.4_supplement.247s","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T17:31:17Z","timestamp":1201023077000},"page":"247S-257S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"S","title":["Aspirin and Other Platelet-Active Drugs"],"prefix":"10.1016","volume":"108","author":[{"given":"Jack","family":"Hirsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Harker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Patrono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.108.4_Supplement.247S_bib1","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106","DOI":"10.1136\/bmj.308.6921.81"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib2","doi-asserted-by":"crossref","unstructured":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9,364 pregnant women. Lancet 1994; 343:619-29","DOI":"10.1016\/S0140-6736(94)92633-6"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib3","doi-asserted-by":"crossref","unstructured":"Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1994; 341:396-400","DOI":"10.1016\/0140-6736(93)92988-6"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib4","doi-asserted-by":"crossref","unstructured":"The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827\u201330","DOI":"10.1016\/0140-6736(90)92336-G"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.STR.24.8.1125","article-title":"Does low-dose acetylsalicylic acid prevent stroke after carotid surgery?: a double-blind, placebo-controlled randomized trial","volume":"24","author":"Lindblad","year":"1993","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib6","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","article-title":"Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris","volume":"340","author":"Juul-Moller","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib7","doi-asserted-by":"crossref","unstructured":"The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325:1261-66","DOI":"10.1056\/NEJM199110313251801"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.1994.00420130030006","article-title":"Atrial fibrillation and stroke: three new studies, three remaining questions","volume":"154","author":"Albers","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib10","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308:235-43","DOI":"10.1136\/bmj.308.6923.235"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.CIR.87.1.162","article-title":"Indobufen in the prevention of thromboembolic complications in patients with heart disease","volume":"87","author":"Fornaro","year":"1993","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5223(94)70392-2","article-title":"Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency 1 year after coronary artery bypass grafting","volume":"107","author":"Rajah","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib13","unstructured":"The SINBA Group. Indobufen versus aspirin plus dipyridamole after coronary artery bypass surgery. Coron Artery Dis 1991; 2: 897\u2013906"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"EPIC","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(94)90007-8","article-title":"Randomized trial of coronary intervention with antibody against platelet Ilb\/IIIa integrin for reduction of clinical restenosis: results at 6 months: the EPIC investigators","volume":"343","author":"Topol","year":"1994","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM198804073181412","article-title":"An overview of the British and American aspirin studies","volume":"318","author":"Hennekens","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.1991.03470040085027","article-title":"A prospective study of aspirin use and primary prevention of cardiovascular disease in women","volume":"266","author":"Manson","year":"1991","journal-title":"JAMA"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib18","doi-asserted-by":"crossref","unstructured":"ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-60","DOI":"10.1016\/S0140-6736(88)92833-4"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib19","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296:320-31","DOI":"10.1136\/bmj.296.6618.320"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrel","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jama.1991.03470020086038","article-title":"A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease","volume":"266","author":"Imperiale","year":"1991","journal-title":"JAMA"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0140-6736(91)93124-R","article-title":"Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial","volume":"337","author":"Uzan","year":"1991","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib23","doi-asserted-by":"crossref","unstructured":"The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338:1345-49","DOI":"10.1016\/0140-6736(91)92233-R"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1993.tb05689.x","article-title":"The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials","volume":"35","author":"Roderick","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-5223(19)36724-8","article-title":"Comparison of two levels of anticoagulant therapy in patients with substitute heart valves","volume":"101","author":"Altman","year":"1991","journal-title":"J Thorac Cardiovase Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","article-title":"Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole","volume":"51","author":"Chesebro","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5223(19)40105-0","article-title":"Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves","volume":"72","author":"Altman","year":"1976","journal-title":"J Thorac Cardiovase Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-8703(80)90625-0","article-title":"Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement","volume":"99","author":"Dale","year":"1980","journal-title":"Am Heart J"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1656307","article-title":"Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation","volume":"68","author":"Meade","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group)","volume":"66","author":"Cohen","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/oxfordjournals.eurheartj.a062576","article-title":"Randomised controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study","volume":"9","author":"Meade","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib32","doi-asserted-by":"crossref","unstructured":"Steering Committtee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321:129-35","DOI":"10.1056\/NEJM198907203210301"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib34","doi-asserted-by":"crossref","unstructured":"Special report: preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322:863-68","DOI":"10.1056\/NEJM199003223221232"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib35","doi-asserted-by":"crossref","unstructured":"Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84:527-39","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib36","doi-asserted-by":"crossref","unstructured":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323:1505-11","DOI":"10.1056\/NEJM199011293232201"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib38","doi-asserted-by":"crossref","unstructured":"EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342:1255-62","DOI":"10.1016\/0140-6736(93)92358-Z"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.STR.25.7.1337","article-title":"Atrial fibrillation and stroke: revisiting the dilemmas","volume":"25","author":"Hart","year":"1994","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib40","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/archinte.1993.00410190057007","article-title":"Prophylactic agents for venous thrombosis in elective hip surgery","volume":"253","author":"Mohr","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib41","series-title":"Basic principles and clinical practice","first-page":"1331","article-title":"Prevention of venous thromboembolism","author":"Gallus","year":"1994"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1055\/s-0038-1651012","article-title":"An evaluation of impedance plethysmography and I-125-fibrinogen leg scanning in patients following hip surgery","volume":"62","author":"Cruickshank","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.1989.00390040013003","article-title":"A randomized trial of less intensive postoperative warfarin and aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip","volume":"149","author":"Powers","year":"1989","journal-title":"Arch Intern Med"},{"issue":"suppl","key":"10.1378\/chest.108.4_Supplement.247S_bib44","first-page":"118","article-title":"RD Heparin (ardeparin sodium) vs aspirin to prevent deep venous thrombosis after hip or knee replacement surgery [abstract]","volume":"102","author":"Graor","year":"1992","journal-title":"Chest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib45","unstructured":"Gent M, Hirsh J, Ginsberg J, et al. The low molecular heparinoid weight orgaran is more effective than aspirin in the prevention of venous thromboembolism following surgery for hip fracture. Circulation (in press)"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2165\/00003495-198734020-00003","article-title":"Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet dependent disease states","volume":"34","author":"Saltiel","year":"1987","journal-title":"Drugs"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1172\/JCI111705","article-title":"Functionally thrombosthenic state in normal platelets following the administration of ticlopidine","volume":"75","author":"Di Minno","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.82.1.17","article-title":"Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter clinical trial","volume":"82","author":"Balsano","year":"1990","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib49","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"2","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/000331978803900904","article-title":"Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications","volume":"39","author":"Arcan","year":"1988","journal-title":"Angiology"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib52","first-page":"84","article-title":"Ticlopidine in the treatment of intermittent claudications: a 21-month double-blind trial","volume":"114","author":"Balsano","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2796.1990.tb00164.x","article-title":"Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine: results from STIMS, the Swedish Ticlopidine Multicentre Study","volume":"227","author":"Janzon","year":"1990","journal-title":"J Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-5223(19)36194-X","article-title":"Prevention of aorta-coronary bypass graft occlusion: beneficial effect of ticlopidine on early and late patency rate of venous coronary bypass grafts: a double-blind study","volume":"94","author":"Limet","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets: I. Acetylation of a particulate fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib56","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1172\/JCI108941","article-title":"Inhibition of platelet prostaglandin synthetase by oral aspirin","volume":"61","author":"Burch","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib58","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1172\/JCI111110","article-title":"Arachidonate metabolism in vascular disorders","volume":"72","author":"Majerus","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-6997(25)06759-6","article-title":"Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane-A2 and prostacyclin","volume":"30","author":"Moncada","year":"1978","journal-title":"Pharmacol Rev"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib60","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","article-title":"Clinical pharmacology of platelet cyclo-oxygenase inhibition","volume":"72","author":"Patrono","year":"1985","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","article-title":"Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients","volume":"308","author":"Weksler","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib62","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib63","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI110814","article-title":"Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198101083040203","article-title":"Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin","volume":"304","author":"Preston","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.CIR.75.5.1025","article-title":"Inhibition of prostaglandin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo","volume":"75","author":"Kyrle","year":"1987","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib66","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib67","unstructured":"AHFS Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, 1992; 1055."},{"key":"10.1378\/chest.108.4_Supplement.247S_bib68","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.STR.25.12.2337","article-title":"Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease","volume":"25","author":"Komiya","year":"1994","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib69","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib70","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.STR.24.10.1458","article-title":"Platelet aggregation in patients with atrial fibrillation taking aspirin or warfarin","volume":"24","author":"Helgason","year":"1993","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3181\/00379727-163-40716","article-title":"The effects of aspirin on megakaryocyte prostaglandin production (40716)","volume":"163","author":"Demers","year":"1980","journal-title":"Proc Soc Exp Biol Bed"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib72","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.75.10.5181","article-title":"Sensitivity of fatty acid cyclo-oxygenase from human aorta to acetylation by aspirin","volume":"75","author":"Burch","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib73","first-page":"196","article-title":"The role of prostaglandins in platelet function","volume":"16","author":"Burch","year":"1979","journal-title":"Semin Hematol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib74","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(80)90334-5","article-title":"Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo","volume":"18","author":"Cerskus","year":"1980","journal-title":"Thromb Res"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(68)92228-9","article-title":"Effects of salicylates on human platelets","volume":"1","author":"O'Brien","year":"1968","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib76","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0002-9149(89)90875-8","article-title":"Superior antiplatelet action of alternative day pulsed dosing","volume":"64","author":"Lorenz","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib77","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI111865","article-title":"Effect of platelet-modifying drugs on arterial thromboembolism in baboons: aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition","volume":"75","author":"Hanson","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib78","doi-asserted-by":"crossref","first-page":"21B","DOI":"10.1016\/S0735-1097(86)80004-3","article-title":"Pharmacology of platelet inhibitors","volume":"8","author":"Harker","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib79","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0049-3848(82)90127-X","article-title":"Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase","volume":"25","author":"Buchanan","year":"1982","journal-title":"Thromb Res"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib80","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1172\/JCI113020","article-title":"Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclo-oxygenase inhibition","volume":"79","author":"Gaspari","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib81","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib82","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib86","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI110059","article-title":"Enhanced platelet accumulation onto injured carotid arteries in rabbits following aspirin treatment","volume":"67","author":"Buchanan","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib87","first-page":"403","article-title":"The effect of aspirin and salicylate on platelet\/vessel wall interactions in rabbits","volume":"4","author":"Buchanan","year":"1984","journal-title":"Atherosclerosis"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib88","doi-asserted-by":"crossref","unstructured":"Persantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation 1980; 62:449-61","DOI":"10.1161\/01.CIR.62.3.449"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib89","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","article-title":"A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction","volume":"1","author":"Elwood","year":"1974","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib90","doi-asserted-by":"crossref","unstructured":"Coronary Drug Project Group. Aspirin in coronary heart disease. J Chronic Dis 1976; 29:625-42","DOI":"10.1016\/0021-9681(76)90020-5"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib91","first-page":"225","article-title":"Secondary prevention of myocardial infarction: comparison of acetylsalicylic acid, phenprocoumon and placebo: a multicenter two-year prospective study","volume":"40","author":"Breddin","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib92","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(79)92808-3","article-title":"Aspirin and secondary mortality after myocardial infarction","volume":"2","author":"Elwood","year":"1979","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib93","doi-asserted-by":"crossref","unstructured":"Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243:661-69","DOI":"10.1001\/jama.1980.03300330019023"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib94","first-page":"413","article-title":"Aspirin in coronary heart disease: comparison of six clinical trials","volume":"19","author":"Canner","year":"1983","journal-title":"Isr J Med Sci"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib95","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.CIR.85.3.1077","article-title":"High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation","volume":"85","author":"Ratnatunga","year":"1992","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib96","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)21331-3","article-title":"Aspirin acetylates fibrinogen and enhances fibrinolysis: fibrinolytic effect is independent of changes in plasminogen activator levels","volume":"250","author":"Bjomsson","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib97","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM197703102961001","article-title":"Increased blood fibrinolytic activity after aspirin ingestion","volume":"296","author":"Moroz","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib98","first-page":"394","article-title":"Fibrinolytic activity after administration of diflunisal and aspirin","volume":"13","author":"Green","year":"1983","journal-title":"Haemostasis"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)25723-8","article-title":"Influence of acetylsalicylic acid and salicylamide on the coagulation of blood","volume":"128","author":"Quick","year":"1960","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib100","first-page":"239","article-title":"Dose-dependent influence of acetylsalicylic acid on platelet functions and plasmatic coagulation factors","volume":"5","author":"Loew","year":"1976","journal-title":"Haemostasis"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-0038-1648815","article-title":"Measurement of thrombin generation in whole blood: the effect of heparin and aspirin","volume":"72","author":"Kessels","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib102","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1182\/blood.V80.8.2006.2006","article-title":"Antiplatelet drugs and generation of thrombin in clotting blood","volume":"80","author":"Szczeklik","year":"1992","journal-title":"Blood"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib103","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/bi00289a010","article-title":"Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase","volume":"22","author":"Roth","year":"1983","journal-title":"Biochemistry"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/219068a0","article-title":"In vitro acetylation of plasma proteins, enzymes and DNA by aspirin","volume":"219","author":"Pinckard","year":"1969","journal-title":"Nature"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib106","doi-asserted-by":"crossref","unstructured":"North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325:445-53","DOI":"10.1056\/NEJM199108153250701"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib107","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/01.STR.24.8.1251","article-title":"Controversies in stroke: past and present: the Willis Lecture","volume":"24","author":"Dyken","year":"1993","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib108","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V83.4.885.885","article-title":"Aspirin, platelets and thrombosis: theory and practice","volume":"83","author":"Roth","year":"1994","journal-title":"Blood"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib109","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJM197405232902102","article-title":"Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease","volume":"290","author":"Levy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib110","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bmj.2.6094.1052","article-title":"Effect of sodium bicarbonate on aspirin-induced damage and potential difference changes in human gastric mucosa","volume":"2","author":"Bowen","year":"1977","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib111","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bmj.298.6672.493","article-title":"Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin","volume":"298","author":"Prichard","year":"1989","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.1988.tb00694.x","article-title":"Prophylaxis of aspirin induced gastric mucosal bleeding with ranitidine","volume":"2","author":"Hawkey","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib113","first-page":"A1401","article-title":"Gastric mucosal bleeding: what dose of aspirin is safe?","volume":"28","author":"Prichard","year":"1987","journal-title":"Gut"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0002-9343(61)90114-0","article-title":"Aspirin and gastrointestinal bleeding: chromate51 blood loss studies","volume":"31","author":"Pierson","year":"1961","journal-title":"Am J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-104-3-390","article-title":"Aspirin and the stomach","volume":"104","author":"Graham","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib116","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0016-5085(88)90487-8","article-title":"Gastric adaptation studies in humans during continuous aspirin administration","volume":"95","author":"Graham","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib117","first-page":"A1411","article-title":"Effect of indomethacin on human gastroduodenal \u2018mucus-bicarbonate\u2019 barrier","volume":"28","author":"Shorrock","year":"1987","journal-title":"Gut"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-91-4-517","article-title":"Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy","volume":"91","author":"Silvoso","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01393353","article-title":"Gastric adaptation occurs with aspirin administration in man","volume":"28","author":"Graham","year":"1983","journal-title":"Dig Dis Sci"},{"issue":"suppl","key":"10.1378\/chest.108.4_Supplement.247S_bib120","first-page":"211","article-title":"Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administrations","volume":"67","author":"O'Laughlin","year":"1981","journal-title":"Seand J Gastroenterol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib121","first-page":"210","article-title":"Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration","volume":"6","author":"Mielants","year":"1979","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.1.5533.137","article-title":"Gastric mucosa and susceptibility to occult gastrointestinal bleeding","volume":"1","author":"Croft","year":"1967","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib123","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(61)80070-X","article-title":"Fecal blood loss produced by oral and intravenous administration of various salicylates","volume":"40","author":"Grossman","year":"1961","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib124","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/bmj.3.5666.330","article-title":"Failure of intravenous aspirin to increase gastrointestinal blood loss","volume":"4","author":"Cooke","year":"1969","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01308304","article-title":"Acute effect of systemic aspirin on gastric mucosa in man","volume":"25","author":"Ivey","year":"1980","journal-title":"Dig Dis Sci"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib126","doi-asserted-by":"crossref","unstructured":"The Steering Committee of the Physicians Health Study Research Group. Special report: preliminary report: findings from the aspirin component of the ongoing physicians' health study. N Engl J Med 1988; 318:262-64","DOI":"10.1056\/NEJM198801283180431"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib127","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-8703(77)80351-7","article-title":"Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves","volume":"94","author":"Dale","year":"1977","journal-title":"Am Heart J"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib129","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM197712082972302","article-title":"Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement","volume":"297","author":"Harris","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.1989.00390040013003","article-title":"A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip","volume":"149","author":"Powers","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0049-3848(79)90267-6","article-title":"Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery","volume":"16","author":"Hull","year":"1979","journal-title":"Thromb Res"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib132","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-89-3-325","article-title":"Aspirin-and Coumadin-related bleeding after coronary-artery bypass graft surgery","volume":"89","author":"Torosian","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib133","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.280.6213.514","article-title":"Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression","volume":"280","author":"McKenna","year":"1980","journal-title":"BMJ"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib134","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2106\/00004623-198264010-00010","article-title":"High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement","volume":"64","author":"Harris","year":"1982","journal-title":"J Bone Joint Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2106\/00004623-198567010-00008","article-title":"Prophylaxis of deep vein thrombosis after total hip replacement: dextran and external compression compared with 1.2 or 0.3 gram of aspirin daily","volume":"67","author":"Harris","year":"1985","journal-title":"J Bone Joint Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib136","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib137","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(84)92446-2","article-title":"Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation","volume":"1","author":"Lorenz","year":"1984","journal-title":"Lancet"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib138","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.72.1.138","article-title":"Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery","volume":"72","author":"Brown","year":"1985","journal-title":"Circulation"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib139","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197909133011103","article-title":"Prevention of thrombosis in patients on hemodialysis by low-dose aspirin","volume":"301","author":"Harter","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u2018AICLA\u2019 controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib141","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","article-title":"A randomized trial of aspirin and sulfinpyrazone in threatened stroke: the Canadian cooperative study group","volume":"299","author":"Barnett","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib142","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","article-title":"Controlled trial of aspirin in cerebral ischemia","volume":"8","author":"Fields","year":"1977","journal-title":"Stroke"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib143","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","article-title":"Dipyridamole","volume":"316","author":"FitzGerald","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib144","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM197012102832402","article-title":"Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves","volume":"283","author":"Harker","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib145","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJM197106242842501","article-title":"Pharmacologic control of thromboembolic complications of cardiac-valve replacement","volume":"284","author":"Sullivan","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib146","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000658-197711000-00009","article-title":"Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function","volume":"158","author":"Harker","year":"1977","journal-title":"Ann Surg"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib147","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitortrial in coronary-artery bypass operations","volume":"307","author":"Chesebro","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib148","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","article-title":"Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations","volume":"310","author":"Chesebro","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib83","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1172\/JCI109332","article-title":"Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin","volume":"63","author":"Jaffe","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0049-3848(80)90283-2","article-title":"Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments","volume":"20","author":"Buchanan","year":"1980","journal-title":"Thromb Res"},{"key":"10.1378\/chest.108.4_Supplement.247S_bib85","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclo-oxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216338971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216338971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:39:14Z","timestamp":1757921954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216338971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["S0012369216338971"],"URL":"https:\/\/doi.org\/10.1378\/chest.108.4_supplement.247s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1995,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and Other Platelet-Active Drugs","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.108.4_Supplement.247S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}